**Education and Professional Experience:** 09/2015-06/2017 The First Affiliated Hospital, Sun Yat-sen University Oncology Ph.D. 09/2005-06/2008 Sun Yat-sen University Cancer Center Oncology Master's Degree 09/2000-07/2005 Tongji Medical College, Huazhong University of Science and Technology Bachelor of Clinical Medicine 04/2013-03/2015 Beth Israel Deaconess Medical Center, Harvard Medical School Postdoctoral Fellow 01/2013-Present The First Affiliated Hospital, Sun Yat-sen University Attending Physician 07/2011-12/2012 The First Affiliated Hospital, Sun Yat-sen University Physician 08/2008-06/2011 Sun Yat-sen University Cancer Center Physician **Professional Affiliations:** Standing Committee Member, Youth Committee, Liver Cancer Committee, Guangdong Anti-Cancer Association Member, Tumor Biotherapy Committee, Guangdong Association of Integrative Medicine Member, Hepatobiliary and Pancreatic Committee, Guangzhou Anti-Cancer Association **Publications (Selected Representative Works):** 1. Peng ZW, Chen SL, Wei MC, et al. Sorafenib with or without Transarterial Chemoembolization plus Radiofrequency Ablation for Advanced Recurrent Hepatocellular Carcinoma. Radiology, in press. IF: 7.296 2. Peng ZW, Wei MC, Chen SL, et al. Combined Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Hepatectomy for Recurrent Hepatocellular carcinoma after Initial Surgery: A Propensity Score Matching study. Euro Radiol, in press. IF: 3.967 3. Chen SL, Peng ZW, Xiao H, et al. Combined Radiofrequency Ablation and Ethanol Injection Versus Repeat Hepatectomy for Elderly Patients with Recurrent Hepatocellular Carcinoma after Initial Hepatic Surgery. Int J Hyperthermia. 2017. Co-first author. IF: 3.262 4. Peng ZW, Rothweiler S, Wei GY, et al. The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis. Hepatol commun. 2017;1:957-972. 5. Peng ZW, Ikenaga N, Liu SB, et al. Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis. Hepatology; 2016;63:217-32. IF: 13.246 6. Xu L, Peng ZW, Chen MS, et al. Prognostic Nomogram for Patients with Unresectable Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization. J Hepatol 2015;63:122-30 Co-first author. IF: 12.486 7. Peng ZW, Zhang YJ, Chen MS et al. Radiofrequency Ablation with or without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial. J Clin Oncol.2013;31;426-432. IF: 24.008 8. Peng ZW, Zhang YJ, Chen MS et al. Recurrent Hepatocellular Carcinoma Treated with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Radiofrequency Ablation Alone: A Prospective Randomized Trial. Radiology. 2012; 262:689-700. IF: 7.296 9. Peng ZW, Zhang YJ, Lin XJ, et al. Radiofrequency ablation vs. hepatic resection for the treatment of hepatocellular carcinomas smaller than 2 cm: A retrospective comparative study. Radiology. 2012; 262:1022-1033. IF: 7.296 10. Peng ZW, Liu FR, Ye S, et al. Radiofrequency ablation versus open hepatic resection for elderly patients (>65 years) with very early or early hepatocellular carcinoma. Cancer. 2013; 119:3812-3820. Co-corresponding author. IF: 5.997 **Other Major Achievements (e.g., Awards):** 1. Comprehensive Treatment of Small Hepatocellular Carcinoma, First Prize of Guangdong Provincial Science and Technology Progress Award 2. Comprehensive Treatment of Small Hepatocellular Carcinoma, Second Prize of the Ministry of Education Science and Technology Progress Award 3. Clinical Study on Percutaneous Radiofrequency Ablation for Small Hepatocellular Carcinoma (2009), Second Prize of the China Anti-Cancer Association Science and Technology Award 4. Third Prize of the "Mr. Deng Anti-Cancer Science Award" from Sun Yat-sen University Cancer Center in 2009 Outstanding Research Award from Sun Yat-sen University in 2007